Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Fampridin, ATC N07XX07
Opportunity Score
Confidence: 50%
Complexity: low
719 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
Open-house model for non-exclusive discount agreements on Fampridine (ATC N07XX07) with AOK Bayern. Any eligible pharmaceutical company can join at any time until 03.06.2028, with contracts running from 01.08.2026 to 31.07.2028. No selection procedure; all eligible companies are accepted. No estimated value provided.
Strengths
Documents available
Open procedure
Low complexity
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Only pharmaceutical companies are eligible as potential contract partners.
- Must submit signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
- Must submit signed contract and signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.
Buyer
Name
AOK Bayern - Die Gesundheitskasse
Location
München, DEU
Identifier
DE811695320
Lots (1)
Rabattvertrag for Fampridine; non-exclusive; all eligible pharmaceutical companies can conclude identical, non-negotiable contracts. Procurement documents must be requested via DTVP portal.
Procurement Details
Publication
14 Jun 2026
Deadline
03 Jun 2028, 10:00
Procedure
open
Contract
supplies
Language
DEU
Publication #
409841-2026
Classification
Performance: Germany
Documents (2)
Opportunity Score
Confidence: 50%
Complexity: low
719 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation